Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines

相似書籍

• Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)
  由: Sewell, J M, et al.
  出版: (2002)
• Gefitinib (‘Iressa’, ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2
  由: Nutt, J E, et al.
  出版: (2004)
• An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines
  由: Sangar, V K, et al.
  出版: (2004)
• Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors
  由: Blackledge, G, et al.
  出版: (2004)
• The effect of ZD1839 (Iressa(TM)), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC‐15 cells
  由: Al‐Hazzaa, A., et al.
  出版: (2005)